Matches in SemOpenAlex for { <https://semopenalex.org/work/W4383346221> ?p ?o ?g. }
- W4383346221 endingPage "3500" @default.
- W4383346221 startingPage "3500" @default.
- W4383346221 abstract "To assess the efficacy of FOLFIRINOX(FFX), gemcitabine-based regimens (GB), and gemcitabine monotherapy (Gem) in patients with metastatic pancreatic ductal adenocarcinoma (mPDAC).This is a retrospective study that included 83 patients with mPDAC treated with first-line chemotherapy (L1) with either FFX, GB or Gem between 2015 and 2017. Progression-free survival (PFS) for L1 and second-line chemotherapy (L2) (PFS-L1 and PFS-L2) and overall survival (OS) were estimated using the Kaplan-Meier method.Median PFS-L1 for FFX, GB and Gem groups was 9 months (95% (Confidence Interval) CI 2.76-15.24), 5 months (95%CI 3.44-6.56), and 5 months (95%CI 3.76-6.24), respectively (p = 0.04). OS was 14 months (95%CI 11.16-16.85), 12 months (95%CI: 9.44-11.56), and 7 months (95%CI: 5.7-8.3) for patients treated with FFX, GB, and Gem, respectively (p = 0.0001). ECOG-PS (0/1) (Hazard Ratio (HR) 6.74, p = 0.002), age > 70 years (HR 0.25, p = 0.04), body tumors (HR 2.8, p = 0.048), CA19-9 > 39 U/mL (HR 0.26, p = 0.02), and neutrophil-to-lymphocyte ratio (NLR) > 4.15 (HR 6.76, p = 0.001) were independent prognostic factors for PFS-L1. Male gender (HR 3.02, p = 0.026), ECOG-PS (0/1) (HR 4.21, p = 0.003), L1 with FFX (HR 0.255, p = 0.007), and NLR > 4.15 (HR 2.65, p = 0.04) were independent prognostic factors of OS. PFS-L2 (HR 6.91, p = 0.013) and OS-L2 (HR 6.95, p = 0.037) were significantly higher in patients first treated with FFX.The OS of patients who receive FFX or GB is comparable. The best PFS-L1 belongs to the FFX group. Male gender, ECOG-PS 0/1, the FFX regimen, and NLR > 4.15 were independent predictors of OS. PFS-L2 and OS-L2 were favorably impacted by L1 with FFX." @default.
- W4383346221 created "2023-07-07" @default.
- W4383346221 creator A5020019924 @default.
- W4383346221 creator A5038707478 @default.
- W4383346221 creator A5040927044 @default.
- W4383346221 creator A5055978007 @default.
- W4383346221 creator A5060822388 @default.
- W4383346221 creator A5062174706 @default.
- W4383346221 creator A5085102462 @default.
- W4383346221 date "2023-07-05" @default.
- W4383346221 modified "2023-09-27" @default.
- W4383346221 title "Real-Life Results of Palliative Chemotherapy in Metastatic Pancreatic Ductal Adenocarcinoma" @default.
- W4383346221 cites W1984052587 @default.
- W4383346221 cites W2045390516 @default.
- W4383346221 cites W2046231757 @default.
- W4383346221 cites W2047945295 @default.
- W4383346221 cites W2085458222 @default.
- W4383346221 cites W2103535624 @default.
- W4383346221 cites W2107780185 @default.
- W4383346221 cites W2122663828 @default.
- W4383346221 cites W2151253787 @default.
- W4383346221 cites W2158798157 @default.
- W4383346221 cites W2165480504 @default.
- W4383346221 cites W2401329952 @default.
- W4383346221 cites W2475987045 @default.
- W4383346221 cites W2604665500 @default.
- W4383346221 cites W2783988406 @default.
- W4383346221 cites W2801349325 @default.
- W4383346221 cites W2897046116 @default.
- W4383346221 cites W2900184152 @default.
- W4383346221 cites W2908221394 @default.
- W4383346221 cites W2913827242 @default.
- W4383346221 cites W2924792717 @default.
- W4383346221 cites W2952588624 @default.
- W4383346221 cites W2976165418 @default.
- W4383346221 cites W3045974418 @default.
- W4383346221 cites W3097776666 @default.
- W4383346221 cites W3183427139 @default.
- W4383346221 cites W3207363546 @default.
- W4383346221 cites W3215857411 @default.
- W4383346221 cites W4313256472 @default.
- W4383346221 doi "https://doi.org/10.3390/cancers15133500" @default.
- W4383346221 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37444612" @default.
- W4383346221 hasPublicationYear "2023" @default.
- W4383346221 type Work @default.
- W4383346221 citedByCount "0" @default.
- W4383346221 crossrefType "journal-article" @default.
- W4383346221 hasAuthorship W4383346221A5020019924 @default.
- W4383346221 hasAuthorship W4383346221A5038707478 @default.
- W4383346221 hasAuthorship W4383346221A5040927044 @default.
- W4383346221 hasAuthorship W4383346221A5055978007 @default.
- W4383346221 hasAuthorship W4383346221A5060822388 @default.
- W4383346221 hasAuthorship W4383346221A5062174706 @default.
- W4383346221 hasAuthorship W4383346221A5085102462 @default.
- W4383346221 hasBestOaLocation W43833462211 @default.
- W4383346221 hasConcept C121608353 @default.
- W4383346221 hasConcept C126322002 @default.
- W4383346221 hasConcept C143998085 @default.
- W4383346221 hasConcept C167135981 @default.
- W4383346221 hasConcept C207103383 @default.
- W4383346221 hasConcept C2776694085 @default.
- W4383346221 hasConcept C2777148230 @default.
- W4383346221 hasConcept C2778963024 @default.
- W4383346221 hasConcept C2780210213 @default.
- W4383346221 hasConcept C2780258809 @default.
- W4383346221 hasConcept C2780739268 @default.
- W4383346221 hasConcept C2780962732 @default.
- W4383346221 hasConcept C2781182431 @default.
- W4383346221 hasConcept C3019894029 @default.
- W4383346221 hasConcept C44249647 @default.
- W4383346221 hasConcept C526805850 @default.
- W4383346221 hasConcept C71924100 @default.
- W4383346221 hasConcept C90924648 @default.
- W4383346221 hasConceptScore W4383346221C121608353 @default.
- W4383346221 hasConceptScore W4383346221C126322002 @default.
- W4383346221 hasConceptScore W4383346221C143998085 @default.
- W4383346221 hasConceptScore W4383346221C167135981 @default.
- W4383346221 hasConceptScore W4383346221C207103383 @default.
- W4383346221 hasConceptScore W4383346221C2776694085 @default.
- W4383346221 hasConceptScore W4383346221C2777148230 @default.
- W4383346221 hasConceptScore W4383346221C2778963024 @default.
- W4383346221 hasConceptScore W4383346221C2780210213 @default.
- W4383346221 hasConceptScore W4383346221C2780258809 @default.
- W4383346221 hasConceptScore W4383346221C2780739268 @default.
- W4383346221 hasConceptScore W4383346221C2780962732 @default.
- W4383346221 hasConceptScore W4383346221C2781182431 @default.
- W4383346221 hasConceptScore W4383346221C3019894029 @default.
- W4383346221 hasConceptScore W4383346221C44249647 @default.
- W4383346221 hasConceptScore W4383346221C526805850 @default.
- W4383346221 hasConceptScore W4383346221C71924100 @default.
- W4383346221 hasConceptScore W4383346221C90924648 @default.
- W4383346221 hasIssue "13" @default.
- W4383346221 hasLocation W43833462211 @default.
- W4383346221 hasLocation W43833462212 @default.
- W4383346221 hasLocation W43833462213 @default.
- W4383346221 hasOpenAccess W4383346221 @default.
- W4383346221 hasPrimaryLocation W43833462211 @default.
- W4383346221 hasRelatedWork W1969578744 @default.